PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sphere of biopharmaceuticals, offering promising breakthroughs across various healthcare and industrial applications. With its structural similarity to Obviously derived human serum albumin, OsrHSA supplies a safer, far more responsible alternate for therapeutic